New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
06:49 EDTACT, LCI, TEVA, MYLGeneric drug prices have risen significantly, NY Times says
The cost of some generic drugs has risen rapidly since last year, according to The New York Times, which cited information from research firm EvaluatePharma. Publicly traded generic drug companies include Teva (TEVA), Mylan (MYL), Actavis (ACT) Impax Laboratories (IPXL), and Lannett (LCI). Reference Link
News For TEVA;MYL;ACT;LCI From The Last 14 Days
Check below for free stories on TEVA;MYL;ACT;LCI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 24, 2014
06:45 EDTTEVATeva price target raised to $70 from $65 at Barclays
Subscribe for More Information
July 23, 2014
10:02 EDTTEVA, MYL, ACTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:10 EDTMYL, ACT, TEVADeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
07:09 EDTMYLMylan wins restraining order against Apotex for generic version of GSK's Paxil
Subscribe for More Information
06:45 EDTMYLLawmakers divided on inversion deals, NY Times says
Subscribe for More Information
July 22, 2014
16:09 EDTACTActavis initiated with a Buy at Deutsche Bank
Subscribe for More Information
16:08 EDTTEVATeva initiated with a Buy at Deutsche Bank
Subscribe for More Information
16:08 EDTMYLMylan initiated with a Buy at Deutsche Bank
Target $67.
July 21, 2014
16:36 EDTACTActavis and Medicines360 announce FDA acceptance of Levosert NDA
Subscribe for More Information
13:23 EDTLCIHigh option volume stocks: RFMD LCI MR PII DG CTRL
Subscribe for More Information
10:31 EDTLCIHigh option volume stocks:
High option volume stocks: EZPW LCI STLD SIAL FL OREX CROX NIHD EXTR BBT
08:11 EDTTEVAArena Pharma' subsidiary enters into agreement for Belviq with Teva subsidiary
Subscribe for More Information
08:01 EDTTEVATeva completes acquisition of Labrys
Subscribe for More Information
July 18, 2014
16:47 EDTMYLMarket ends week higher as earnings, M&A offset geopolitical tensions
Subscribe for More Information
12:51 EDTMYLKey GOP senator signals readiness for inversion deal, The Hill says
Subscribe for More Information
07:56 EDTLCILannett signs agreement with Symplmed
Lannett announced that it has signed an agreement with Symplmed to be the exclusive distributor in the U.S. of an authorized generic version of ACEON in 2 mg, 4 mg and 8 mg dosage strengths. According to IMS, annual total sales of Perindopril Erbumine Tablets, 2 mg, 4 mg and 8 mg, at Average Wholesale Price were approximately $3.5M. The company expects to commence shipping the product shortly.
July 17, 2014
15:42 EDTACTDepomed says Actavis preliminarily enjoined from marketing generic Gralise
Subscribe for More Information
11:07 EDTMYLAcorda sues Mylan over plans to duplicate Ampyra MS drug, Bloomberg says
08:56 EDTLCILannett decline on Connecticut probe seems overdone, says Roth Capital
After Lannett fell 17% following the disclosure that it had received subpoenas from Connecticut regarding the pricing of digoxin, Roth Capital does not expect the state to take any further action against the company. The firm does not believe that there has been any collusion on digoxin prices. It keeps a $45 price target and Buy rating on the shares.
07:18 EDTMYLMylan wins motion to enjoin GlaxoSmithKline from production of generic product
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use